Indian market enters tougher phase as easy gains fade, stock picking becomes key: Ambit

Indian market enters tougher phase as easy gains fade, stock picking becomes key: Ambit

Indian equities are moving into a more demanding phase, where broad-based gains are giving way to selective opportunities and sharper differences across stocks. Dhiraj Agarwal, Managing Director at Ambit Investment Managers, says the market no longer offers easy, momentum-driven returns. “Easy, easy, easy money is not there. It’s back to basics. There are money-making opportunities,…

Read More
Why global investors are turning cautious on India despite its growth promise

Why global investors are turning cautious on India despite its growth promise

Global investors are turning cautious on India despite its strong long-term growth promise, as concerns around artificial intelligence (AI) disruption and a recent slowdown in positive economic surprises weigh on sentiment, according to Jacob Pedersen, Head of Equity Research at AL Sydbank. Pedersen said that while India continues to be viewed as a structurally attractive…

Read More
GIC Re receives ₹350 crore income tax demand notice for FY23; to file appeal at NFAC

GIC Re receives ₹350 crore income tax demand notice for FY23; to file appeal at NFAC

State-owned reinsurer General Insurance Corporation of India (GIC Re) on Friday (April 10) said it has received a notice of demand under Section 156 of the Income Tax Act, 1961, from the Income Tax Department’s Assessment Unit for Assessment Year 2023-24, amounting to ₹350.47 crore. The order includes an assessment under Section 143(3) along with the…

Read More
Torrent Pharma's Gujarat oncology plant inspection by USFDA concludes with zero observations

Torrent Pharma’s Gujarat oncology plant inspection by USFDA concludes with zero observations

Pharmaceutical company, Torrent Pharmaceuticals Ltd, on Friday (April 10), said the US Food and Drug Administration (USFDA) inspected its Bileshwarpura (Oncology) facility in Gujarat, from April 6, 2026, to April 10, 2026. The inspection has been concluded with zero observations. Third Quarter Results Torrent Pharmaceuticals reported a net profit of ₹635 crore in Q3 FY26,…

Read More
Adani wins US court hearing in push to throw out SEC fraud suit

Adani Energy Solutions crosses 1 crore smart meters; network at 27,949 ckm in FY26

Adani Energy Solutions Ltd (AESL) on Friday (April 10) reported operational progress across its transmission, distribution and smart metering businesses in Q4 FY26, including the commissioning of its second high-voltage direct current (HVDC) project and surpassing 1 crore cumulative smart meter installations. The company commissioned the Mumbai HVDC Project during the quarter, which strengthens the…

Read More
Mahindra & Mahindra to divest stake in Erkunt Foundry; deal signed with Turkish buyers

Mahindra & Mahindra to divest stake in Erkunt Foundry; deal signed with Turkish buyers

Mahindra & Mahindra Ltd on Friday (April 10) said its wholly-owned subsidiary Mahindra Overseas Investment Company (Mauritius) Ltd (MOICML), and its subsidiary Erkunt Traktör Sanayii Anonim Şirketi have entered into a stock purchase agreement to sell their entire 99.04% stake in Erkunt Sanayi Anonim Şirketi (Erkunt Foundry). The agreement was signed on April 10, 2026,…

Read More